Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Applied StemCell provides advanced gene editing and induced pluripotent stem cell (iPSC) technologies as well as cGMP-compliant manufacturing capabilities to support the discovery, development, and production of next-generation allogeneic therapies. The company's offerings include custom disease models, master cell line generation for antibody/protein production, iPSC derivation/editing/expansion/banking under GMP conditions, animal model generation using CRISPR or TARGATT™, and related CRO/CDMO services. There are no reported clinical results as the company does not develop its own therapeutics but supports others' programs from basic research through preclinical stages.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Applied StemCell.